Skip to main content

Nanobiotechnology and Personalized Medicine

  • Chapter
  • First Online:
The Handbook of Nanomedicine

Abstract

Personalized medicine simply means the prescription of specific therapeutics best suited for an individual. It is usually based on pharmacogenetic, pharmacogenomic, transcriptomic, pharmacoproteomic and pharmacometabolomic information. Other individual variations in patients and environmental factors are also taken into consideration (Jain 2015). Personalized medicine means improving healthcare by incorporating early detection of disease, preventive medicine, rational drug discovery and development, and monitoring of therapy. Concept of personalized medicine as systems medicine is the best way of integrating new technologies and translating them into clinical application for improving healthcare. Application of nanobiotechnology is described for personalized management of cancer and cardiovascular disorders. Advances in nanobiotechnology will facilitate the development of personalized medicine by:

  • Nanodiagnostics will improve the sensitivity and extend the present limits of molecular diagnostics/molecular imaging of CNS disorders.

  • Nanotechnology can be integrated in detection of biomarkers, POC devices, biochips and biosensors.

  • Biomarkers discovered by use of nanodiagnostics will facilitate the development of new personalized drugs for various disorders.

  • Nanobiotechnology will facilitate integration of diagnosis and therapy, which is an important part personalized medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Berguig GY, Convertine AJ, Frayo S. Intracellular delivery system for antibody-peptide drug conjugates. Mol Ther. 2015;23:907–17.

    Article  Google Scholar 

  • Chan LW, Wang X, Wei H. A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis. Sci Transl Med. 2015;7:277ra29.

    Article  Google Scholar 

  • Jaffer FA, Libby P, Weissleder R. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1017–24.

    Article  Google Scholar 

  • Jain KK. Role of nanodiagnostics in personalized cancer therapy. Clin Lab Med. 2012;32:15–31.

    Article  Google Scholar 

  • Jain KK. Textbook of personalized medicine. 2nd ed. New York: Springer; 2015.

    Google Scholar 

  • Kwon EJ, Lo JH, Bhatia SN. Smart nanosystems: bio-inspired technologies that interact with the host environment. Proc Natl Acad Sci U S A. 2015;112:14460–6.

    Article  Google Scholar 

  • Lal R, Arnsdorf MF. Multidimensional atomic force microscopy for drug discovery: a versatile tool for defining targets, designing therapeutics and monitoring their efficacy. Life Sci. 2010;86:545–62.

    Article  Google Scholar 

  • Singh N, Agrawal A, Leung AK, et al. Effect of nanoparticle conjugation on gene silencing by RNA interference. J Am Chem Soc. 2010;132:8241–3.

    Article  Google Scholar 

  • Sowers MA, McCombs J, Wang Y, et al. Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging. Nat Commun. 2014;5:5460.

    Article  Google Scholar 

  • Srivastava A, Babu A, Filant J, et al. Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer. J Biomed Nanotechnol. 2016;12:1159–73.

    Article  Google Scholar 

  • Sykes EA, Dai Q, Sarsons CD, et al. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc Natl Acad Sci U S A. 2016;113:E1142–51.

    Article  Google Scholar 

  • Tripathi SK, Kaur G, Khurana RK, et al. Quantum dots and their potential role in cancer theranostics. Crit Rev Ther Drug Carrier Syst. 2015;32:461–502.

    Article  Google Scholar 

  • Veiseh O, Tang BC, Whitehead KA, et al. Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov. 2015;14:45–57.

    Article  Google Scholar 

  • Warren AD, Gaylord ST, Ngan KC, et al. Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers. J Am Chem Soc. 2014;136:13709–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Jain, K.K. (2017). Nanobiotechnology and Personalized Medicine. In: The Handbook of Nanomedicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6966-1_16

Download citation

Publish with us

Policies and ethics